SEC Form 4 · accession 0001562180-16-002188
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amy Wolbeck
Officer — V.P. Regulatory Affairs & Qlty
Period of report
Apr 27, 2016
Accepted (ET)
Apr 28, 2016 · 9:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 27, 2016 | M | 2,000 | $0.72 | A | 7,700 | D | |
| Common StockF2 | Apr 27, 2016 | S | 2,000 | $20.0075 | D | 5,700 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $0.72 | Apr 27, 2016 | M | 2,000 | D | — | Jan 31, 2021 | Common Stock | 2,000 | 14,720 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2015.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.02, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote on this Form 4.
- F3The shares subject to the option are immediately exercisable. 1/48th of the shares subject to the option vest monthly over 48 months beginning January 30, 2013.